Celsion ( CLSN) Company Profile: Celsion is an oncology drug-development company. Current Share Price: $2.64 (April 26) Listing Violation: Market value/equity/net income. Celsion does not comply with the minimum $35 million market value of listed securities requirement for continued listing on the Nasdaq. Received Nasdaq Notice: April 6 Management's Expected Action: Celsion has until Oct. 3 to regain compliance with the listing requirement, which means the company's market value of listed securities must close at $35 million or more for a minimum of 10 consecutive trading days. Celsion said it is evaluating all possible means by which the company may regain sustained compliance with the rule.